View of Small-Molecule PD-L1 Modulators as Alternatives to Checkpoint Antibodies: Implications for Infection-Associated Immune Toxicities

Return to Issue Details Small-Molecule PD-L1 Modulators as Alternatives to Checkpoint Antibodies: Implications for Infection-Associated Immune Toxicities Download Download PDF